OOIR: Observatory of International Research

Papers

(The TQCC of JNCI-Journal of the National Cancer Institute is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group	306
Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics	270
Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study	167
Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy	156
Clinical Characteristics and Outcomes of COVID-19–Infected Cancer Patients: A Systematic Review and Meta-Analysis	138
“When Offered to Participate”: A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials	113
The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis	112
State Variation in Low-Dose Computed Tomography Scanning for Lung Cancer Screening in the United States	111
Real-World Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer	106
Management of Cancer and Health After the Clinic Visit: A Call to Action for Self-Management in Cancer Care	103
Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial	98
Annual Report to the Nation on the Status of Cancer, Part 2: Patient Economic Burden Associated With Cancer Care	95
Physical Activity Before, During, and After Chemotherapy for High-Risk Breast Cancer: Relationships With Survival	93
Serum Concentrations of Per- and Polyfluoroalkyl Substances and Risk of Renal Cell Carcinoma	89
Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling	89
Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated Non-Small Cell Lung Cancer	83
International Trends in the Incidence of Cancer Among Adolescents and Young Adults	78
PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus nab-Paclitaxel–Treated Advanced Triple-Negative Breast Cancer	78
Prostate Cancer Incidence 5 Years After US Preventive Services Task Force Recommendations Against Screening	77
Accuracy and Efficiency of Deep-Learning–Based Automation of Dual Stain Cytology in Cervical Cancer Screening	76
Association of Antibiotic Exposure With Survival and Toxicity in Patients With Melanoma Receiving Immunotherapy	76
Effect of Aspirin on Cancer Incidence and Mortality in Older Adults	75
Using Prediction Models to Reduce Persistent Racial and Ethnic Disparities in the Draft 2020 USPSTF Lung Cancer Screening Guidelines	73
Cancer Misinformation and Harmful Information on Facebook and Other Social Media: A Brief Report	72
Changes in Mammography Use by Women’s Characteristics During the First 5 Months of the COVID-19 Pandemic	69

Association of the COVID-19 Pandemic With Patterns of Statewide Cancer Services	67
Cancer Stage, Treatment, and Survival Among Transgender Patients in the United States	67
Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis	66
Prevalence and Outcome of COVID-19 Infection in Cancer Patients: A National Veterans Affairs Study	66
A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers	63
Incident Type 2 Diabetes Duration and Cancer Risk: A Prospective Study in Two US Cohorts	60
Comprehensive Assessment of Diet Quality and Risk of Precursors of Early-Onset Colorectal Cancer	59
Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER+ Advanced Breast Cancer	58
The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing Cohort	57
Health Insurance Coverage Disruptions and Cancer Care and Outcomes: Systematic Review of Published Research	57
Estimation of the Number of Individuals Living With Metastatic Cancer in the United States	57
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial	56
Pathological Tumor Response Following Immune Checkpoint Blockade for Deficient Mismatch Repair Advanced Colorectal Cancer	56
Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine Among Actively Treated Cancer Patients	56
Strategies to Prevent or Remediate Cancer and Treatment-Related Aging	55
Germline Cancer Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report From the Children’s Oncology Group	54
Overall Survival of CDK4/6-Inhibitor–Based Treatments in Clinically Relevant Subgroups of Metastatic Breast Cancer: Systematic Review and Meta-Analysis	54
A Transcriptome-Wide Association Study Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer	54
Association Between Sex and Immune-Related Adverse Events During Immune Checkpoint Inhibitor Therapy	54
Evidence Gaps in Cancer Survivorship Care: A Report From the 2019 National Cancer Institute Cancer Survivorship Workshop	52
The Affordable Care Act’s Medicaid Expansion and Impact Along the Cancer-Care Continuum: A Systematic Review	51
All-Cause and Cardiovascular Disease Mortality Among Breast Cancer Survivors in CLUE II, a Long-Standing Community-Based Cohort	50
Performance of Digital Breast Tomosynthesis, Synthetic Mammography, and Digital Mammography in Breast Cancer Screening: A Systematic Review and Meta-Analysis	49
A Prognostic Predictive System Based on Deep Learning for Locoregionally Advanced Nasopharyngeal Carcinoma	48
Association of Obesity With Breast Cancer Outcome in Relation to Cancer Subtypes: A Meta-Analysis	48
Tumor Microenvironment Immune Response in Pancreatic Ductal Adenocarcinoma Patients Treated With Neoadjuvant Therapy	47
Breast Tumor Microenvironment in Black Women: A Distinct Signature of CD8+ T-Cell Exhaustion	47
Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial Cancer	47
Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women	46
Measuring Self-Reported Cancer-Related Cognitive Impairment: Recommendations From the Cancer Neuroscience Initiative Working Group	45
Rural–Urban Disparities in Cancer Outcomes: Opportunities for Future Research	45
Comparing the Cost-Effectiveness of Innovative Colorectal Cancer Screening Tests	45
Long-Term Cause-Specific Mortality in Hodgkin Lymphoma Patients	44
Racial and Ethnic Variation in PSA Testing and Prostate Cancer Incidence Following the 2012 USPSTF Recommendation	43
Scaling Up the Surveillance of Childhood Cancer: A Global Roadmap	43
Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study	43
Sex and Adverse Events of Adjuvant Chemotherapy in Colon Cancer: An Analysis of 34 640 Patients in the ACCENT Database	42
Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk	42
Cost-Effectiveness of Magnetic Resonance Imaging Screening for Women With Extremely Dense Breast Tissue	41
Evaluating Polygenic Risk Scores for Breast Cancer in Women of African Ancestry	41
The Mortality and Overall Survival Trends of Primary Liver Cancer in the United States	41
Germline MBD4 Mutations and Predisposition to Uveal Melanoma	40
The COVID-19 Pandemic: Identifying Adaptive Solutions for Colorectal Cancer Screening in Underserved Communities	39
Epigenetic Age Acceleration and Chronic Health Conditions Among Adult Survivors of Childhood Cancer	39
p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women	38
Evaluation of a Multiethnic Polygenic Risk Score Model for Prostate Cancer	38
Germline Sequencing DNA Repair Genes in 5545 Men With Aggressive and Nonaggressive Prostate Cancer	37
Medical Financial Hardship in Survivors of Adolescent and Young Adult Cancer in the United States	37
Early-Onset Pancreas Cancer: Clinical Descriptors, Genomics, and Outcomes	36
Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy	35

Associations Between Glycemic Traits and Colorectal Cancer: A Mendelian Randomization Analysis	35
Incidence Trends and Burden of Human Papillomavirus-Associated Cancers Among Women in the United States, 2001-2017	34
Recommended Definitions of Aggressive Prostate Cancer for Etiologic Epidemiologic Research	34
Real-World Effectiveness of Human Papillomavirus Vaccination Against Vulvovaginal High-Grade Precancerous Lesions and Cancers	33
Cost-Effectiveness of Smoking Cessation Interventions in the Lung Cancer Screening Setting: A Simulation Study	33
Survivorship for Individuals Living With Advanced and Metastatic Cancers: National Cancer Institute Meeting Report	33
KRAS and BRAF Mutations in Stage II and III Colon Cancer: A Systematic Review and Meta-Analysis	32
Neoadjuvant Immunotherapy for High-Risk, Resectable Malignancies: Scientific Rationale and Clinical Challenges	32
Personalizing Breast Cancer Screening Based on Polygenic Risk and Family History	32
Disparities in Cancer Survival Among Adolescents and Young Adults: A Population-Based Study of 88 000 Patients	32
Targeted eHealth Intervention to Reduce Breast Cancer Survivors’ Fear of Recurrence: Results From the FoRtitude Randomized Trial	32
The Impact of COVID-19 on Clinical Trial Execution at the Dana-Farber Cancer Institute	31
Poverty and Targeted Immunotherapy: Survival in Children’s Oncology Group Clinical Trials for High-Risk Neuroblastoma	31
BRCA1Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-Analysis	31
Antibiotics Use and Subsequent Risk of Colorectal Cancer: A Swedish Nationwide Population-Based Study	30
Breast Cancer Screening Trials: Endpoints and Overdiagnosis	30
Side Effects 15 Years After Lymph Node Irradiation in Breast Cancer: Randomized EORTC Trial 22922/10925	30
Deficit Accumulation Frailty Trajectories of Older Breast Cancer Survivors and Non-Cancer Controls: The Thinking and Living With Cancer Study	29
Smoking Cessation Prevalence and Inequalities in the United States: 2014-2019	28
Determining PD-L1 Status in Patients With Triple-Negative Breast Cancer: Lessons Learned From IMpassion130	28
Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study	28
Association of Medical Financial Hardship and Mortality Among Cancer Survivors in the United States	28
Body Mass Index and Risk of Second Cancer Among Women With Breast Cancer	28
Wedding of Molecular Alterations and Immune Checkpoint Blockade: Genomics as a Matchmaker	27
Body Mass Index and Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer	27
CD4/CD8 Ratio and Cancer Risk Among Adults With HIV	27
Predicting the Pathologic Complete Response After Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer	27
Homologous Recombination Deficiency Alterations in Colorectal Cancer: Clinical, Molecular, and Prognostic Implications	27
Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies	27
Identifying Novel Causes of Cancers to Enhance Cancer Prevention: New Strategies Are Needed	26
The Role of Mendelian Randomization Studies in Deciphering the Effect of Obesity on Cancer	26
S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients	26
Underreporting of Symptomatic Adverse Events in Phase I Clinical Trials	25
Site of Recurrence and Survival After Surgery for Colorectal Peritoneal Metastasis	25
Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial	25
Optimizing Survival and the Changing Landscape of Targeted Therapy for Intermediate and Advanced Hepatocellular Carcinoma: A Systematic Review	24
Survival in Young-Onset Metastatic Colorectal Cancer: Findings From Cancer and Leukemia Group B (Alliance)/SWOG 80405	24
NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis	24
Timing of Aspirin Use in Colorectal Cancer Chemoprevention: A Prospective Cohort Study	24
An Artificial Intelligence System for the Detection of Bladder Cancer via Cystoscopy: A Multicenter Diagnostic Study	24
The Effect of Metformin vs Placebo on Sex Hormones in Canadian Cancer Trials Group MA.32	23
Deep Learning vs Traditional Breast Cancer Risk Models to Support Risk-Based Mammography Screening	23
Temporal Trends in Opioid Prescribing Patterns Among Oncologists in the Medicare Population	23
Smoking History as a Potential Predictor of Immune Checkpoint Inhibitor Efficacy in Metastatic Non-Small Cell Lung Cancer	23
Use of Straighteners and Other Hair Products and Incident Uterine Cancer	23
Patient-Reported Outcomes in Clinical Trials Leading to Cancer Immunotherapy Drug Approvals From 2011 to 2018: A Systematic Review	23
Cellular Telephone Use and the Risk of Brain Tumors: Update of the UK Million Women Study	23
Racial Disparities in Recurrence and Overall Survival in Patients With Locoregional Colorectal Cancer	23
Readdressing the Needs of Cancer Survivors During COVID-19: A Path Forward	23
Impact of Stopping Trastuzumab in Early Breast Cancer: A Population-Based Study in Ontario, Canada	23
Gender Differences in Treatment Allocation and Survival of Advanced Gastroesophageal Cancer: A Population-Based Study	23
Incidence of Lung Cancer Among Never-Smoking Asian American, Native Hawaiian, and Pacific Islander Females	22
Clinical Implications of Body Mass Index in Metastatic Breast Cancer Patients Treated With Abemaciclib and Endocrine Therapy	22
The Anatomy and Physiology of Teaming in Cancer Care Delivery: A Conceptual Framework	22
Clinicopathological and Molecular Characteristics of Early-Onset Stage III Colon Adenocarcinoma: An Analysis of the ACCENT Database	22
Sex-Specific Associations Between Chemotherapy, Chronic Conditions, and Neurocognitive Impairment in Acute Lymphoblastic Leukemia Survivors: A Report From the Childhood Cancer Survivor Study	22
Early Medicaid Expansion and Cancer Mortality	22
Cost-Effectiveness of Nasopharyngeal Carcinoma Screening With Epstein-Barr Virus Polymerase Chain Reaction or Serology in High-Incidence Populations Worldwide	22
Quality of Life With Pembrolizumab for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: KEYNOTE-040	22
The Impact of Breast Density Information or Notification on Women’s Cognitive, Psychological, and Behavioral Outcomes: A Systematic Review	22
Heterozygous BRCA1 and BRCA2 and Mismatch Repair Gene Pathogenic Variants in Children and Adolescents With Cancer	21
Developing and Sustaining an Effective and Resilient Oncology Careforce: Opportunities for Action	21
Multicancer Early Detection: Learning From the Past to Meet the Future	21
Associations of Aspirin and Non-Aspirin Non-Steroidal Anti-Inflammatory Drugs With Colorectal Cancer Mortality After Diagnosis	21
Increased CD8+ T-cell Infiltration and Efficacy for Multikinase Inhibitors After PD-1 Blockade in Hepatocellular Carcinoma	21
Addressing Complementary and Alternative Medicine Use Among Individuals With Cancer: An Integrative Review and Clinical Practice Guideline	21
Enduring Cancer Disparities by Persistent Poverty, Rurality, and Race: 1990-1992 to 2014-2018	21
Lifetime Benefits and Harms of Prostate-Specific Antigen–Based Risk-Stratified Screening for Prostate Cancer	21
Age Is Just a Number: Considerations for Older Adults in Cancer Clinical Trials	21
Serial Analysis of Circulating Tumor Cells in Metastatic Breast Cancer Receiving First-Line Chemotherapy	21
Performance of Breast Cancer Polygenic Risk Scores in 760 FemaleCHEK2Germline Mutation Carriers	20
Association Between Medicaid Expansion Under the Affordable Care Act and Survival Among Newly Diagnosed Cancer Patients	20
An Imaging Biomarker of Tumor-Infiltrating Lymphocytes to Risk-Stratify Patients With HPV-Associated Oropharyngeal Cancer	20
Employment Outcomes Among Cancer Survivors in the United States: Implications for Cancer Care Delivery	20
FOLFIRINOX as Initial Treatment for Localized Pancreatic Adenocarcinoma: A Retrospective Analysis by the Trans-Atlantic Pancreatic Surgery Consortium	20
The Oral Microbiome and Lung Cancer Risk: An Analysis of 3 Prospective Cohort Studies	20
The Impact of Intensifying Prostate Cancer Screening in Black Men: A Model-Based Analysis	19
Racial Disparities in Epigenetic Aging of the Right vs Left Colon	19
Advanced Breast Cancer Definitions by Staging System Examined in the Breast Cancer Surveillance Consortium	19
Multiple Primary Melanoma Incidence Trends Over Five Decades: A Nationwide Population-Based Study	19

Long-Term Colorectal Cancer Incidence and Mortality After Colonoscopy Screening According to Individuals’ Risk Profiles	19
BRAFV600E Mutation in First-Line Metastatic Colorectal Cancer: An Analysis of Individual Patient Data From the ARCAD Database	18
Central Adiposity and Subsequent Risk of Breast Cancer by Menopause Status	18
Essentialism and Exclusion: Racism in Cancer Risk Prediction Models	18
Germline SUCLG2 Variants in Patients With Pheochromocytoma and Paraganglioma	18
Cumulative Advanced Breast Cancer Risk Prediction Model Developed in a Screening Mammography Population	18
Patient-Reported Outcomes in Pediatric Cancer Registration Trials: A US Food and Drug Administration Perspective	18
Impact of Full-Field Digital Mammography Versus Film-Screen Mammography in Population Screening: A Meta-Analysis	18
Quality of Life in Older Adults After Major Cancer Surgery: The GOSAFE International Study	18
21-Gene Assay and Breast Cancer Mortality in Ductal Carcinoma In Situ	17
Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast Cancer	17
Summary From the First Kidney Cancer Research Summit, September 12–13, 2019: A Focus on Translational Research	17
Novel Biomarkers of Habitual Alcohol Intake and Associations With Risk of Pancreatic and Liver Cancers and Liver Disease Mortality	17
A Systematic Review of Estimating Breast Cancer Recurrence at the Population Level With Administrative Data	17
The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study	16
Clonal Hematopoiesis–Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian Cancer	16
Long-Term Neurocognitive and Psychosocial Outcomes After Acute Myeloid Leukemia: A Childhood Cancer Survivor Study Report	16
Cancer Incidence in World Trade Center Rescue and Recovery Workers: 14 Years of Follow-Up	16
Effect of the p53 P72R Polymorphism on MutantTP53Allele Selection in Human Cancer	16
Smoking and Incidence of Colorectal Cancer Subclassified by Tumor-Associated Macrophage Infiltrates	16
Molecular Features and Functional Implications of Germline Variants in Triple-Negative Breast Cancer	16
Long-Term Risk of Ovarian Cancer and Borderline Tumors After Assisted Reproductive Technology	16
A Gene-Expression Predictor for Efficacy of Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma	16
Breast and Prostate Cancer Risks for MaleBRCA1andBRCA2Pathogenic Variant Carriers Using Polygenic Risk Scores	16
Subsequent Primary Cancer Risk Among 5-Year Survivors of Adolescent and Young Adult Cancers	15
COVID-19, Social Justice, and Clinical Cancer Research	15
Progression of Frailty in Survivors of Childhood Cancer: A St. Jude Lifetime Cohort Report	15
Long-Term Outcomes With Pharmacological Ovarian Suppression During Chemotherapy in Premenopausal Early Breast Cancer Patients	15
Identification of the JNK-Active Triple-Negative Breast Cancer Cluster Associated With an Immunosuppressive Tumor Microenvironment	15
Association ofGATA3Polymorphisms With Minimal Residual Disease and Relapse Risk in Childhood Acute Lymphoblastic Leukemia	15
Cost-Sharing and Out-of-Pocket Cost for Women Who Received MRI for Breast Cancer Screening	15
Dopamine Receptor Antagonists, Radiation, and Cholesterol Biosynthesis in Mouse Models of Glioblastoma	15
SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1–Negative Lung Adenocarcinomas	15
Body Size at Different Ages and Risk of 6 Cancers: A Mendelian Randomization and Prospective Cohort Study	15
Computational Image Analysis of T-Cell Infiltrates in Resectable Gastric Cancer: Association with Survival and Molecular Subtypes	15
Addressing Transportation Insecurity Among Patients With Cancer	15
Trends of Cancer-Related Suicide in the United States: 1999-2018	15
Housing Insecurity Among Patients With Cancer	15
Changes in survival in de novo metastatic cancer in an era of new medicines	14
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry	14
Clinicopathological Features and Outcomes Comparing Patients With Invasive Ductal and Lobular Breast Cancer	14
Inclusion of a core patient-reported outcomes battery in adolescent and young adult cancer clinical trials	14
Real-World Use of Bone-Modifying Agents in Metastatic Castration-Sensitive Prostate Cancer	14
Patient-Reported Outcomes for Tolerability Assessment in Phase I Cancer Clinical Trials	14
Association of Body Mass Index With Colorectal Cancer Risk by Genome-Wide Variants	14
Association of Medicaid Expansion With Cancer Stage and Disparities in Newly Diagnosed Young Adults	14
Behavioral Research in Cancer Prevention and Control: Emerging Challenges and Opportunities	14
A Comparison of Late Mortality Among Survivors of Childhood Cancer in the United States and United Kingdom	14
A Randomized Trial of Telephone-Based Smoking Cessation Treatment in the Lung Cancer Screening Setting	14
Effect of Early Palliative Care on Quality of Life of Advanced Head and Neck Cancer Patients: A Phase III Trial	14
Trends in the incidence of young-onset colorectal cancer with a focus on years approaching screening age: A population-based longitudinal study	14
The Global Landscape of Treatment Standards for Breast Cancer	13
Impact of Blinding on Patient-Reported Outcome Differences Between Treatment Arms in Cancer Randomized Controlled Trials	13
Risk Stratification for Early-Onset Colorectal Cancer Using a Combination of Genetic and Environmental Risk Scores: An International Multi-Center Study	13
Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune features	13
Comparing 5-Year and Lifetime Risks of Breast Cancer using the Prospective Family Study Cohort	13
The Survival Impact of Second Primary Lung Cancer in Patients With Lung Cancer	13
Housing and Cancer Care and Outcomes: A Systematic Review	13
Distinct Reproductive Risk Profiles for Intrinsic-Like Breast Cancer Subtypes: Pooled Analysis of Population-Based Studies	13
Tumor Cellularity and Infiltrating Lymphocytes as a Survival Surrogate in HER2-Positive Breast Cancer	13
An Evaluation of Sex- and Gender-Based Analyses in Oncology Clinical Trials	13
Cancer Hazard Evaluations for Contemporary Needs: Highlights From New National Toxicology Program Evaluations and Methodological Advancements	13
Overcoming the challenges to implementation of artificial intelligence in pathology	13
Informing Women About Overdetection in Breast Cancer Screening: Two-Year Outcomes From a Randomized Trial	13
Impact of HIV on Anal Squamous Cell Carcinoma Rates in the United States, 2001-2015	13
Financial Toxicity in Adolescent and Young Adult Cancer Survivors: Proposed Directions for Future Research	12
Decreasing Incidence of Estrogen Receptor–Negative Breast Cancer in the United States: Trends by Race and Region	12
Prevalence of Flavored e-Cigarette Use Among Subpopulations of Adults in the United States	12
How the Coronavirus Disease-2019 May Improve Care: Rethinking Cervical Cancer Prevention	12
Risk of Rare Cancers Among Solid Organ Transplant Recipients	12
Comparison of Treatments for Nonmetastatic Castration-Resistant Prostate Cancer: Matching-Adjusted Indirect Comparison and Network Meta-Analysis	12
Study design considerations for trials to evaluate multicancer early detection assays for clinical utility	12
Incidence of in Situ vs Invasive Melanoma: Testing the “Obligate Precursor” Hypothesis	12
Food Insecurity Among People With Cancer: Nutritional Needs as an Essential Component of Care	12
Genomic Risk Score for Melanoma in a Prospective Study of Older Individuals	12
Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome	12
Cardiovascular Care of the Oncology Patient During COVID-19: An Expert Consensus Document From the ACC Cardio-Oncology and Imaging Councils	12
Risk of Pancreatic Cancer in the Long-Term Prospective Follow-Up of Familial Pancreatic Cancer Kindreds	12
Sleep Disruption, Fatigue, and Depression as Predictors of 6-Year Clinical Outcomes Following Allogeneic Hematopoietic Cell Transplantation	12
Grade Migration of Prostate Cancer in the United States During the Last Decade	12
Cardiovascular Disease in Breast Cancer Survivors: An Important Topic in Breast Cancer Survivorship	12
Common Susceptibility Loci for Male Breast Cancer	12
Patient-Reported Outcomes and Long-Term Nonadherence to Aromatase Inhibitors	12
Recommendations for Epstein-Barr virus–based screening for nasopharyngeal cancer in high- and intermediate-risk regions	12
Proportion of Patients in Phase I Oncology Trials Receiving Treatments That Are Ultimately Approved	12
Addressing Social Determinants of Health: Now Is the Time	11
Interactions of Age and Blood Immune Factors and Noninvasive Prediction of Glioma Survival	11
Risk of Metabolic and Cardiovascular Adverse Events With Abiraterone or Enzalutamide Among Men With Advanced Prostate Cancer	11
Urinary Thromboxane B2 and Lethal Prostate Cancer in African American Men	11
Speeding implementation in cancer: The National Cancer Institute’s Implementation Science Centers in Cancer Control	11
Inferences About Drug Safety in Phase III Trials in Oncology: Examples From Advanced Prostate Cancer	11
Association of Health-Care System With Prostate Cancer-Specific Mortality in African American and Non-Hispanic White Men	11
Assessment of Ovarian Function in Phase III (Neo)Adjuvant Breast Cancer Clinical Trials: A Systematic Evaluation	11
Cervical Precancers and Cancers Attributed to HPV Types by Race and Ethnicity: Implications for Vaccination, Screening, and Management	11
EGFR Amplification in Metastatic Colorectal Cancer	11